Salt Lake City, Utah, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced that on February 6, ...
How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
Former Detroit Lions defender Tracy Scroggins has died at the age of 56. His family stated that he battled the effects of chronic traumatic encephalopathy (CTE). Scroggins played 10 seasons for the ...
The Tomball Independent school district in Texas has invested significantly in its career and technical education programming in recent years. This included buying the property of a bankrupt ...
The former high school football player who killed four people inside a Manhattan office tower that houses the headquarters of the NFL, and who blamed the league for hiding the dangers of brain ...
The latest report on CTE is both enlightening and alarming. As the Boston Herald reported, a groundbreaking study from Boston University researchers found that those with CTE have a much higher chance ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results